Brown Forman (BF-B) PT Lowered to $66 at Bernstein SocGen Group

Brown Forman (BF-B) PT Lowered to $48 at Wedbush

Wedbush analyst Gerald Pascarelli lowered the price target on Brown Forman (NYSE: BF-B) to $48.00 (from $54.00) while maintaining a Neutral rating.... More

Brown Forman (BF-B) PT Lowered to $45 at Morgan Stanley

Morgan Stanley analyst Eric Serotta lowered the price target on Brown Forman (NYSE: BF-B) to $45.00 (from $58.00) while maintaining a Equalweight rating.... More

Brown Forman (BF-B) PT Lowered to $48 at UBS

UBS analyst Peter Grom lowered the price target on Brown Forman (NYSE: BF-B) to $48.00 (from $59.00) while maintaining a Neutral rating.... More

Brown Forman (BF-B) PT Lowered to $43 at Goldman Sachs

Goldman Sachs analyst Bonnie Herzog lowered the price target on Brown Forman (NYSE: BF-B) to $43.00 (from $50.00) while maintaining a Sell rating.... More

Brown Forman (BF-B) PT Lowered to $49 at RBC Capital

RBC Capital analyst Nik Modi lowered the price target on Brown Forman (NYSE: BF-B) to $49.00 (from $56.00) while maintaining a Sector Perform rating.

The analyst comments "This feels like a recurring theme but another quarter of pressure for BF.B as the spirits category... More

Brown Forman (BF-B) PT Lowered to $50 at Evercore ISI

Evercore ISI analyst Robert Ottenstein lowered the price target on Brown Forman (NYSE: BF-B) to $50.00 (from $55.00) while maintaining a In Line rating.

The analyst comments "We urge investors who look for great assets at attractive valuations to do work on the... More

Citi Reiterates Neutral Rating on Brown Forman (BF-B)

Citi analyst Filippo Falorni reiterated a Neutral rating and $48.00 price target on Brown Forman (NYSE: BF-B).

The analyst comments "BFB reported fiscal 4Q24 EPS of $0.56 or an estimated $0.27 adjusted for a ~$177M gain on sale on the Sonoma-Cutrer divestiture vs. consensus of $0.42 and our... More